Tamara Hannon
Pediatric Endocrinology · Indianapolis, INNPI 1750354510
Payments from drug & device makers
What this record shows
This record is dominated by education: $101 of the $116 with a category attached, or 86.7%. Abbott accounts for 86.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for pediatric endocrinology clinicians in IN, where the typical reported total is $4,834.
Across 3 payments — averaging $38.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$101
- Mannkind Corporation$16
Across 746 payments — averaging $761.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$403K
- Novo Nordisk AS$121K
- Takeda Pharmaceuticals U.S.A., Inc.$44K
What the payments were for
- Food & beverage$1613%
- Education$10187%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 2 | $101 |
| Mannkind Corporation | 1 | $16 |
How this compares
$116 in reported general payments places this provider in the 20th percentile of 27 pediatric endocrinology providers in Indiana.
Other pediatric endocrinology in Indianapolis
- Gordon CutlerIndianapolis$305K
- Emily SimsIndianapolis$236K
- Linda di MeglioIndianapolis$96K
- Erik ImelIndianapolis$69K
- Jamie FeltonIndianapolis$34K
- Erica EugsterIndianapolis$21K
- John FuquaIndianapolis$20K
- Rebecca AguirreIndianapolis$13K
- Hebatullah IsmailIndianapolis$9K
- Eric ChangIndianapolis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.